Central Laboratory, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210006, P.R. China.
Oncol Rep. 2018 May;39(5):2201-2208. doi: 10.3892/or.2018.6309. Epub 2018 Mar 12.
Recently, miR‑485‑5p was identified as a tumor‑suppressing microRNA in some human cancers. However, the expression and biological role of miR‑485‑5p in colorectal cancer (CRC) remain unclear. Herein, we found that the expression of miR‑485‑5p in CRC tissues and cell lines was much lower than that in the control, respectively. Moreover, the overexpression of miR‑485‑5p could inhibit the proliferation and invasion of CRC cell lines in vitro and in vivo. Furthermore, we determined that miR‑485‑5p could decrease the expression of CD147 by directly targeting CD147 3'UTR. In addition, the expression of CD147 was inversely correlated with the expression of miR‑485‑5p in CRC tissues. Collectively, our results revealed that miR‑485‑5p played a pivotal tumor‑suppressing role in CRC through downregulation of cancer‑associated gene CD147, and may provide a better understanding of the pathogenesis in CRC and a new bio‑target for CRC therapy.
最近,miR-485-5p 被鉴定为一些人类癌症中的肿瘤抑制 microRNA。然而,miR-485-5p 在结直肠癌(CRC)中的表达和生物学作用仍不清楚。在此,我们发现 miR-485-5p 在 CRC 组织和细胞系中的表达明显低于对照。此外,miR-485-5p 的过表达可抑制 CRC 细胞系在体外和体内的增殖和侵袭。此外,我们确定 miR-485-5p 可以通过直接靶向 CD147 3'UTR 来降低 CD147 的表达。此外,CRC 组织中 CD147 的表达与 miR-485-5p 的表达呈负相关。总之,我们的结果表明,miR-485-5p 通过下调癌相关基因 CD147 在 CRC 中发挥关键的肿瘤抑制作用,可能为 CRC 的发病机制提供更好的理解,并为 CRC 的治疗提供新的生物靶点。